Question 1

How does paclitaxel from Taxus brevifolia work against cancer?

Accepted Answer

Paclitaxel, originally isolated from Pacific yew bark, works by stabilizing microtubules in cells, preventing their normal breakdown during cell division. This action arrests cancer cells in the mitosis phase, ultimately leading to programmed cell death. The compound binds to the β-tubulin subunit, promoting microtubule assembly while inhibiting disassembly. This mechanism makes it particularly effective against rapidly dividing cancer cells, including ovarian, breast, and lung cancers. Evidence level: A for pharmaceutical paclitaxel mechanism.

Question 2

What are the drug interactions of paclitaxel from Pacific yew?

Accepted Answer

Pharmaceutical paclitaxel has clinically significant drug interactions, particularly with medications metabolized by CYP2C8 and CYP3A4 enzymes. Concurrent use with other taxane chemotherapy agents increases toxicity risk. Raw Taxus brevifolia plant material should never be combined with any medications due to lethal taxine alkaloids that cause cardiac arrest. Patients receiving paclitaxel chemotherapy must inform their oncologist about all prescription medications, supplements, and herbal products to prevent dangerous interactions. Evidence level: A for pharmaceutical interactions.

Question 3

What is the recommended dosage of Taxus brevifolia bark?

Accepted Answer

There is no safe recommended dosage for raw Taxus brevifolia bark or any plant part. All parts of Pacific yew contain toxic taxine alkaloids that cause fatal cardiac arrhythmias. Paclitaxel is only available as a regulated pharmaceutical drug administered intravenously under oncologist supervision at doses of 135-175 mg/m² per cycle. The raw plant should never be used for self-treatment. Traditional Native American preparations required specific methods not safely reproducible without expert knowledge. Evidence level: Traditional use only; no clinical dosage data for raw plant.

Question 4

Is Pacific yew safe during pregnancy and breastfeeding?

Accepted Answer

No, Taxus brevifolia is absolutely unsafe during pregnancy and breastfeeding. The plant contains taxine alkaloids that cross the placenta and can cause fetal harm, miscarriage, or maternal death. Pharmaceutical paclitaxel is classified as pregnancy category D with documented fetal harm. Even handling plant material should be avoided during pregnancy. Toxic compounds can pass into breast milk, endangering nursing infants. Women of childbearing age receiving paclitaxel therapy must use effective contraception during and after treatment. Evidence level: C for plant safety; A for pharmaceutical contraindication.

Question 5

Is Taxus brevifolia poisonous to humans?

Accepted Answer

Yes, all parts of Taxus brevifolia are highly poisonous to humans and animals. The plant contains taxine alkaloids, particularly taxine B, which cause rapid-onset cardiac arrhythmias that can lead to death within hours of ingestion. There is no specific antidote for taxine poisoning. Even small amounts of bark, needles, or seeds can be fatal. The plant should never be ingested or used for home remedies. Pharmaceutical paclitaxel requires specialized extraction and processing to isolate the therapeutic compound while removing toxic components. Evidence level: C for toxicity data.

Question 6

What did Native Americans use Pacific yew for traditionally?

Accepted Answer

Pacific Northwest Native American tribes traditionally used Taxus brevifolia for minor aches, pains, and skin conditions, typically as poultices or topical washes from prepared plant parts. However, the plant contains lethal taxine alkaloids, and traditional preparation methods were specific and carefully controlled by experienced practitioners. These traditional uses should not be attempted without expert guidance. The tree gained modern significance as the original natural source of paclitaxel, a major anticancer drug now produced through pharmaceutical semi-synthesis to protect the species from overharvesting. Evidence level: Traditional use only.

Taxus brevifolia

Sources et citations

Résumé

Contexte

Composés actifs

Mécanisme d'action

Preuves cliniques

Sécurité et effets indésirables

Synthèse des preuves

Sources PubMed

Sources gouvernementales